BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20048176)

  • 1. Circulating serum free light chains as predictive markers of AIDS-related lymphoma.
    Landgren O; Goedert JJ; Rabkin CS; Wilson WH; Dunleavy K; Kyle RA; Katzmann JA; Rajkumar SV; Engels EA
    J Clin Oncol; 2010 Feb; 28(5):773-9. PubMed ID: 20048176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.
    Bibas M; Trotta MP; Cozzi-Lepri A; Lorenzini P; Pinnetti C; Rizzardini G; Angarano G; Caramello P; Sighinolfi L; Mastroianni CM; Mazzarello G; Di Caro A; Di Giacomo C; d'Arminio Monforte A; Antinori A;
    Am J Hematol; 2012 Aug; 87(8):749-53. PubMed ID: 22718364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals.
    Shiels MS; Landgren O; Costello R; Zingone A; Goedert JJ; Engels EA
    Clin Infect Dis; 2012 Nov; 55(10):e103-8. PubMed ID: 22893577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.
    Engels EA; Preiksaitis J; Zingone A; Landgren O
    Am J Transplant; 2012 May; 12(5):1268-74. PubMed ID: 22300426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma.
    Witzig TE; Maurer MJ; Habermann TM; Link BK; Micallef IN; Nowakowski GS; Ansell SM; Colgan JP; Inwards DJ; Porrata LF; Markovic SN; Johnston PB; Lin Y; Thompson C; Gupta M; Katzmann JA; Cerhan JR
    Am J Hematol; 2014 Dec; 89(12):1116-20. PubMed ID: 25228125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma.
    Maurer MJ; Micallef IN; Cerhan JR; Katzmann JA; Link BK; Colgan JP; Habermann TM; Inwards DJ; Markovic SN; Ansell SM; Porrata LF; Johnston PB; Nowakowski GS; Thompson CA; Gupta M; Syrbu SI; Kurtin PJ; Macon WR; Nikcevich DA; Witzig TE
    J Clin Oncol; 2011 Apr; 29(12):1620-6. PubMed ID: 21383282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of immunoglobulin free light chains in patients with chronic hepatitis C presenting cryoglobulinemia.
    Oliveira IS; Cabral MS; Jesus LS; Paraná R; Atta AM; Sousa Atta ML
    Braz J Infect Dis; 2014; 18(6):638-42. PubMed ID: 25193081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
    Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
    Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients.
    Engels EA; Savoldo B; Pfeiffer RM; Costello R; Zingone A; Heslop HE; Landgren O
    Transplantation; 2013 Feb; 95(3):519-26. PubMed ID: 23222884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.
    Maurer MJ; Cerhan JR; Katzmann JA; Link BK; Allmer C; Zent CS; Call TG; Rabe KG; Hanson CA; Kay NE; Slager SL; Witzig TE; Shanafelt TD
    Blood; 2011 Sep; 118(10):2821-6. PubMed ID: 21765023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.
    Shepherd L; Borges ÁH; Harvey R; Bower M; Grulich A; Silverberg M; Weber J; Ristola M; Viard JP; Bogner JR; Gargalianos-Kakolyris P; Mussini C; Mansinho K; Yust I; Paduta D; Jilich D; Smiatacz T; Radoi R; Tomazic J; Plomgaard P; Frikke-Schmidt R; Lundgren J; Mocroft A;
    HIV Med; 2018 Feb; 19(2):90-101. PubMed ID: 28857427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy.
    Evliyaoglu O; van Helden J; Jaruschewski S; Imöhl M; Weiskirchen R
    Clin Biochem; 2019 Dec; 74():42-46. PubMed ID: 31526775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum free light chains in patients with HIV infection: their association with markers of disease severity and antiretroviral use.
    Zemlin AE; Ipp H; Rensburg MA; Germishuys JJ; Esser MM; Olivier M; Erasmus RT
    J Clin Pathol; 2015 Feb; 68(2):148-53. PubMed ID: 25452398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms.
    Pardanani A; Lasho TL; Finke CM; Rajkumar SV; Singh PP; Ketterling RP; Hanson CA; Katzmann JA; Tefferi A
    J Clin Oncol; 2012 Apr; 30(10):1087-94. PubMed ID: 22331938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
    Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
    AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
    Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
    Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
    Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
    Jaskowski TD; Litwin CM; Hill HR
    Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.